The chrono-pharmacological targeting of the CCL2 and its receptor c-c motif chemokine receptor 2 (CCR2) inhibits atherosclerosis in ApoE-/- mice (Winter et al., 2018). This evidence concerns the gene CCR2 and atherosclerosis.